Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2013 1
2014 3
2016 1
2017 1
2019 2
2020 3
2021 2
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Inmune-mediated inflammatory rheumatic diseases in transgender people: A scoping review.
Salgado E, Romera-Baurés M, Beltran-Catalan E, Naredo E, Carreira PE, Garcia-Vivar M, Moreno-Muelas JV, Boteanu A, Calvo-Penades I, Sellas-Fernandez A, Valero M, Gomez-Reino JJ. Salgado E, et al. Among authors: beltran catalan e. Semin Arthritis Rheum. 2022 Feb;52:151920. doi: 10.1016/j.semarthrit.2021.10.004. Epub 2021 Oct 28. Semin Arthritis Rheum. 2022. PMID: 34872742 Review.
SER recommendations for the treatment of uveitis.
Beltrán Catalán E, Brito García N, Pato Cour E, Muñoz Fernández S, Gómez Gómez A, Díaz Valle D, Hernández Garfella M, Francisco Hernández FM, Trujillo Martín MDM, Silva Fernández L, Villanueva G, Suárez Cuba J, Blanco R. Beltrán Catalán E, et al. Reumatol Clin (Engl Ed). 2023 Nov;19(9):465-477. doi: 10.1016/j.reumae.2023.07.003. Epub 2023 Oct 13. Reumatol Clin (Engl Ed). 2023. PMID: 37839964 Free article.
Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients.
Martín-Varillas JL, Sanchez-Bilbao L, Calvo-Río V, Adán A, Hernanz I, Gallego-Flores A, Beltran-Catalan E, Castro-Oreiro S, Fanlo P, Garcia Martos A, Torre I, Cordero-Coma M, De Dios JR, García-Aparicio Á, Hernández-Garfella M, Sánchez-Andrade A, García-Valle A, Maiz O, Miguélez R, Rodríguez-Montero S, Urruticoechea A, Veroz R, Conesa A, Fernández-Carballido C, Jovaní V, Mondejar JJ, Martínez González O, Moya Alvarado P, Romero-Yuste S, Rubio-Muñoz P, Peña-Sainz-Pardo E, Garijo-Bufort M, Demetrio-Pablo R, Hernández JL, Blanco R. Martín-Varillas JL, et al. Among authors: beltran catalan e. RMD Open. 2022 Dec;8(2):e002693. doi: 10.1136/rmdopen-2022-002693. RMD Open. 2022. PMID: 36597972 Free PMC article.
RE: Author reply:
Martínez-Costa L, Trentini FJ, Ibañez MV, Murcia-Bello C, Epifanio I, Verdejo-Gimeno C, Beltrán-Catalán E, Marco-Ventura P. Martínez-Costa L, et al. Among authors: beltran catalan e. Can J Ophthalmol. 2014 Jun;49(3):308. doi: 10.1016/j.jcjo.2014.04.005. Can J Ophthalmol. 2014. PMID: 24862783 No abstract available.
Multidisciplinary Management of the Adverse Effects of Apremilast.
Daudén Tello E, Alonso Suárez J, Beltrán Catalán E, Blasco Maldonado C, Herrero Manso MC, Jiménez Morales A, Marín-Jiménez I, Martín-Arranz MD, García-Merino A, Porta Etessam J, Rodríguez-Sagrado MA, Rosas Gómez de Salazar J, Trujillo Martín E, Salgado-Boquete L. Daudén Tello E, et al. Among authors: beltran catalan e. Actas Dermosifiliogr (Engl Ed). 2021 Feb;112(2):134-141. doi: 10.1016/j.ad.2020.08.007. Epub 2020 Sep 7. Actas Dermosifiliogr (Engl Ed). 2021. PMID: 32910923 Free article. English, Spanish.
Tocilizumab in uveitis refractory to other biologic drugs: a study of 3 cases and a literature review.
Calvo-Río V, de la Hera D, Beltrán-Catalán E, Blanco R, Hernandez M, Martínez-Costa L, Loricera J, Cañal J, Ventosa J, Ortiz-Sanjuán F, Pina T, González-Vela MC, Rodríguez-Cundín P, González-Gay MA. Calvo-Río V, et al. Among authors: beltran catalan e. Clin Exp Rheumatol. 2014 Jul-Aug;32(4 Suppl 84):S54-7. Epub 2014 Jul 8. Clin Exp Rheumatol. 2014. PMID: 25005576 Review.
Golimumab in uveitis previously treated with other anti-TNF-alpha drugs: a retrospective study of three cases from a single centre and literature review.
Calvo-Río V, de la Hera D, Blanco R, Beltrán-Catalán E, Loricera J, Cañal J, Ventosa J, Cifrián JM, Ortiz-Sanjuán F, Rueda-Gotor J, González-Vela MC, González-López M, González-Gay MA. Calvo-Río V, et al. Among authors: beltran catalan e. Clin Exp Rheumatol. 2014 Nov-Dec;32(6):864-8. Epub 2014 Oct 2. Clin Exp Rheumatol. 2014. PMID: 25288110 Review.
CRMP-5-IgG Antibody: role in the bilateral uveitis with swollen disc.
Hernández-Bel L, Puchades-Gimeno F, Fernandez-Diaz A, Mata-Moret L, Beltrán-Catalán E, Hernandez-Garfella ML, Cervera-Taulet E. Hernández-Bel L, et al. Among authors: beltran catalan e. Rom J Ophthalmol. 2020 Apr-Jun;64(2):217-221. Rom J Ophthalmol. 2020. PMID: 32685790 Free PMC article.
Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practice.
Gratacós-Masmitja J, Beltrán Catalán E, Álvarez Vega JL, Urruticoechea-Arana A, Fito C, Maceiras F, Belzunegui Otano JM, Fernández Melón J, Chamizo Carmona E, Abad Hernández MÁ, Ros Vilamajó I, Castro Oreiro S, Pascual Alfonso E, Torre Alonso JC; PREVAIL team. Gratacós-Masmitja J, et al. Among authors: beltran catalan e. Reumatol Clin (Engl Ed). 2024 Jan;20(1):24-31. doi: 10.1016/j.reumae.2023.09.004. Reumatol Clin (Engl Ed). 2024. PMID: 38233009 Free article.
Development of an activity disease score in patients with uveitis (UVEDAI).
Pato E, Martin-Martinez MA, Castelló A, Méndez-Fernandez R, Muñoz-Fernández S, Cordero-Coma M, Martinez-Costa L, Valls E, Reyes M, Francisco F, Esteban M, Fonollosa A, Sanchez-Alonso F, Fernández-Espartero C, Diaz-Valle T, Carrasco JM, Beltran-Catalán E, Hernández-Garfella M, Hernández MV, Pelegrin L, Blanco R, Diaz-Valle D. Pato E, et al. Among authors: beltran catalan e. Rheumatol Int. 2017 Apr;37(4):647-656. doi: 10.1007/s00296-016-3593-1. Epub 2016 Nov 4. Rheumatol Int. 2017. PMID: 27815703 Free PMC article.
14 results